Homburger advised Novartis AG on its USD 12 bn acquisition of Avidity Biosciences, Inc.
On March 2, 2026, Novartis AG (SIX: NOVN / NYSE: NVS), acting through one of its wholly-owned indirect subsidiaries,
Homburger advised EQT on the sale of ca. 14.3% of Galderma’s share capital via an accelerated bookbuilding process exiting in full their investment
On March 10, 2026, a consortium led by EQT, consisting of Sunshine SwissCo GmbH, the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers), announced the launch of an accelerated
Homburger advised Roche Holding in the refinancing of its USD 7.5 bn revolving credit facility
On March 6, 2026, Roche Holding AG, Roche Holdings, Inc. and Roche Finanz AG entered into a Swiss law governed USD 7.5 bn revolving credit facility agreement arranged by and syndicated among twelve international banks, coordinated by Deutsche Bank.
Homburger advised Element Solutions on the acquisition of Micromax from Celanese
On February 2, 2026, Element Solutions Inc (NYSE: ESI), a global and diversified specialty chemicals technology company, announced that it has completed its previously announced acquisition of Micromax from Celanese Corporation (NYSE: CE) for approximately USD 500 m in cash.
Mourant’s Jersey Funds team celebrates success in the 31st annual Monterey Jersey Fund Report
Mourant, an international professional services firm, has secured its position as the top legal adviser to all funds serviced in Jersey according to the 2025 Monterey Fund Report.
Strengthening our presence at a key hub for European investment and regulation to provide timely, high‑quality legal services
Anderson Mori & Tomotsune (Chiyoda-ku, Tokyo; “AMT”) is pleased to announce the establishment of its Paris office, further strengthening its European presence and enhancing its ability to support clients in France and across Europe.
BUREN strengthens its corporate notarial practice with the appointment of Rutger van Thiel as partner
The Hague, 3 March 2026 – BUREN is pleased to announce that Rutger van Thiel joined the firm on 1 March 2026 as partner and prospective civil-law notary within the Corporate Notarial practice.
ARQIS begleitet Greenovis beim Zusammenschluss mit der grün ER leben GmbH
Düsseldorf, 6. März 2026 – ARQIS hat die Greenovis Group bei der weiteren Expansion und ihrem Zusammenschluss mit der grün ER leben GmbH umfassend rechtlich beraten. Damit setzt Greenovis den Wachstumskurs durch den Zugang des Unternehmens aus Werne bei Dortmund konsequent fort und ergänzt das Leistungsportfolio im Pflegesegment des Garten- und Landschaftsbaus. Der Gründer und …
Continue reading “ARQIS begleitet Greenovis beim Zusammenschluss mit der grün ER leben GmbH”
Homburger advised ADC Therapeutics on the amendment of the financing agreement with HealthCare Royalty
On February 23, 2026, ADC Therapeutics SA (NYSE: ADCT) announced that it had amended its royalty purchase agreement with entities managed by HealthCare Royalty.
Yulchon: M&A Highlights 2025
Yulchon celebrates a year of transformative transactions across technology, mobility, energy transition, financial services and consumer sectors.